Tighe D, Thomas A J, Hills A, Quadros R
William Harvey Hospital, EKHUFT, Ashford, KENT TN24 0LZ.
School of Computing, Engineering and Mathematics, University of Brighton, East Sussex, UK.
Br J Oral Maxillofac Surg. 2019 Nov;57(9):873-879. doi: 10.1016/j.bjoms.2019.07.008. Epub 2019 Jul 26.
The aim of this study was to validate a case-mix adjustment tool (neural network) for the audit of postoperative outcomes. We tested its calibration and discrimination on two unseen groups of patients being treated for squamous cell carcinoma (SCC) of the head and neck and compared observed complication rates with predicted rates. A total of 196 patients who were treated at two UK NHS institutions between 2016 and 2018 were audited. Preoperative data pertaining to risk (T classification, complexity of operation, and "high-risk" status) were collected, together with data on postoperative complications. Diagnostic test statistics and receiver operating curves (ROC) were used to test the performance of the tool. The score was well calibrated (predicted and observed complication rates both 43%), but discrimination suggested only fair accuracy (ROC 0.66 - 0.68). Adjustment of case mix for the audit of postoperative complications is difficult, although our model suggests that departmental audit is possible, and its accuracy is equivalent to that of other national audits. Further work may elucidate key variables that have not yet been assessed.
本研究的目的是验证一种用于术后结果审计的病例组合调整工具(神经网络)。我们在两组未经观察的头颈部鳞状细胞癌(SCC)患者中测试了其校准和区分能力,并将观察到的并发症发生率与预测发生率进行了比较。对2016年至2018年期间在英国两家国民健康服务(NHS)机构接受治疗的196例患者进行了审计。收集了与风险相关的术前数据(T分类、手术复杂性和“高风险”状态)以及术后并发症数据。使用诊断测试统计数据和受试者工作特征曲线(ROC)来测试该工具的性能。该评分校准良好(预测和观察到的并发症发生率均为43%),但区分能力表明准确性仅为中等(ROC为0.66 - 0.68)。尽管我们的模型表明部门审计是可行的,且其准确性与其他国家审计相当,但对术后并发症审计进行病例组合调整仍很困难。进一步的研究可能会阐明尚未评估的关键变量。